# Aptamer Name Aptamer Target (General) Aptamer Target (Specific) Length Affinity Buffer GC Content Sequence Reference
371 HIV-1 Integrase (P5) (ID# 129) Protein HIV-1 Integrase 77 10 nM Buffer A (50 mM HEPES, 1 mM DTT, 1 mM APMSF) Binding Buffer (50 mM Na-HEPES (pH 7.5), 250 mM NaCl, 2 mM DTT, 10 mM MnCl2, 5 mM CHAPS) 54.55% 5' GGGAGCUCAGAAUAAACGCUCAACCAGUCUUGUGGCUUUGAAAGAGAGGAGUGUUCGACAUGAGGCCCGGAUCCGGC 3' Allen, P., et al. "Isolation of High-Affinity RNA Ligands to HIV-1 Integrase from a Random Pool." Virology, 209(1995): 327-336.
372 Rev Peptide (ID# 258) Peptide Rev Peptide 77 18 µM Buffer (50 mM Tris, pH 7.5, 100 mM KCl, 10 mM MgCl2) 59.74% 5' GGACCUCGGCGAAAGCCGGUAACGCCACAAGUCGGAGGGUAAGAUCUGACAGGAACUGGGUGACGGAGGUUAGGUGC 3' Hesselberth et al. "Simultaneous detection of diverse analytes with an aptazyme ligase array." Analytical Biochemistry, 312(2003): 106-112.
373 HIV-1 Rev Peptide (L1-Rev) (ID# 413) Peptide HIV-1 Rev Peptide 77 18 µM Reaction buffer: 20 mM Tris-HCl, pH 7.5, 50 mM NaCl, and 60 mM MgCl2 59.74% 5' GGACCUCGGCGAAAGCCGGUAACGCCACAAGUCGGAGGGUAAGAUCUGACAGGAACUGGGUGACGGAGGUUAGGUGC 3' Hesslberth et al. "Simultaneous Detection of Diverse Analytes with an Aptazyme Ligase Array." Analytical Biochemistry, 312, (2003):106-112.
374 Terminal 8-oxodG DNA Lesion (R10-B35) (ID# 488) Small Organic DNA Lesion 7,8-dihydro-8-hydroxy-2'-deoxyguanosine (8-oxodG) 78 5 µM  Binding buffer: 20 mM NH4CH3CO2(pH 6.0), 300 mM NaCl, and 5 mM MgCl2. 50.00% 5' GGGCGAAUUCCCGAGGACCAAAUAGUACCACCCGGGAAAACAGCUAAUGCCGAAACGGAGAUUUUUUCUGCAGAAGCU 3' Rink, S. M. et al. "Creation of RNA molecules that recognize the oxidative lesion 7,8-dihydro-8-hydroxy-2*-deoxyguanosine (8-oxodG) in DNA." Proc. Natl. Acad. Sci., 95 (1998):11619-11624.
375 ATP C20 (ID# 572) Small Organic ATP 78 39 µM (50 mM Tris–HCl, pH 7.5, 150 mM NaCl, 5 mM MgCl2) + 1 mg/ml tRNA and 0.1 mg/ml BSA 53.33% Weill L., Louis D., and Sargueil B., 2004.Selection and Evolution of NTP-Specific Aptamers. Nucleic Acids Research, 2004 Vol. 32 No. 17, 5045-5058
376 2F11-14 (ID# 581) Protein Ebola virus inhibitory domain (eVP35 IID) (EBOV) (eVP35) 78 7.1 nM 10mM HEPES (pH 7.0), 150mM NaCl, 2mM TCEP (tris(2-carboxyethyl)phosphine), 1mM MgCl2 56.41% Jennifer M. Binning, Tianjiao Wang, Priya Luthra, Reed S. Shabman, Dominika M. Borek, Gai Liu, Wei Xu, Daisy W. Leung, Christopher F. Basler, and Gaya K. Amarasinghe, ƒ??Development of RNA aptamers targeting ebolavirus VP35ƒ? Biochemistry 2013, 52, 8406-8419.
377 HER3 (A30) (ID# 62) Protein HER3 79 45 nM Binding buffer: 10 mM HEPES (pH 7.4), 100 mM NaCl, and 2.5 mM MgCl2 59.49% 5' GAAUUCCGCGUGUGCCAGCGAAAGUUGCGUAUGGGUCACAUCGCAGGCACAUGUCAUCUGGGCGGUCCGUUCGGGAUCC 3' Chi-Hong et al. "Inhibition of heregulin signaling by an aptamer that preferentially binds to the oligomeric form of human epidermal growth factor receptor-3." Proceedings of the National Academy of Sciences of the United States of America 100,(2003):9226-9231.
378 Lysozyme (ID# 162) Protein Lysozyme 79 31 nM Selection Buffer (20 mM Tris (pH 7.5) 100 mM NaCl,5 mM MgCl2) 45.57% 5' GGGAAUGGAUCCACAUCUACGAAUUCAUCAGGGCUAAAGAGGCAGAGUUACUUAGUUCACUGCAGACUUGACGAAGCUU 3' Cox and Ellington. "Automated Selection of Anti-Protein Aptamers." Bioorganic & Medicinal Chemsitry, 9 (2001): 2525-2531/
379 Heteroaryl dihydropyrimidine (Aptamer 21) (ID# 201) Small Organic Heteroaryldihydropyrimidine (HAP) 79 50 nM  Selection buffer: 150 mM NaCl, 5 mM MgCl2, and 50 mM HEPES (pH 7.4) 56.96% 5' GGGUAGGCCAGGCAGCCAACUAGCGAGAGCUUAAAUCUCUGAGCCCGAGAGGGUUCAGUGCUGCUUAUGUGGACGGCUU 3' Lau et al. "Evolution and Protein Packaging of Small-Molecule RNA Aptamers." ACS NANO, 5(2011): 7722-7729.
380 Mouse Transferrin Receptor (FB4) (ID# 451) Protein Mouse Transferrin Receptor (mTfR) 79 N/A nM RNA binding buffer (20 mM NaPO4, pH 7.4/120 mM NaCl/2.5 mM KCl/0.12 mM MgSO4/40 mM Hepes, pH 7.4) 62.03% 5' GGGCGAAUUCCGCGUGUGCUGAGGGCGGAAGAACUAAUUUGGGACGGAUUGCGGCCGUUGUCUGUGGCGUCCGUUCGGG 3' E F Neufeld et al. Aptamer-based endocytosis of a lysosomal enzyme. Proc. Natl. Acad. Sci. USA 105(2008): 15908-15913